Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / abbvie revises q1 earnings outlook as immunogen deal

ABBV - AbbVie revises Q1 earnings outlook as ImmunoGen deal closes

AbbVie Inc.

2024-02-12 08:14:34 ET

AbbVie ( NYSE: ABBV ) has updated its earnings outlook for the first quarter of 2024 to reflect a dilutive impact related to its acquisition of cancer drugmaker ImmunoGen ( NASDAQ: IMGN )....

For further details see:

AbbVie revises Q1 earnings outlook as ImmunoGen deal closes
Stock Information
Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvie.com
Menu
ABBV ABBV Quote ABBV Short ABBV News ABBV Articles ABBV Message Board
Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...